Metabolic disorders in men with primary gout and hypertension syndrome

Authors

  • І. O. Daniuk

DOI:

https://doi.org/10.14739/2310-1210.2015.3.44484

Keywords:

Uric Acid, Hyperuricemia, Gout, Hypertension, Metabolic Syndrome X

Abstract

Aim. Hyperuricemia іs often associated with clusters of metabolic syndrome, that is why some authors determine hyperuricemia as a component of the metabolic syndrome. 50 men with primary gout combined with hypertension syndrome, 30 primary gout men without hypertension, 30 men with essential hypertension and 20 healthy men were examined for the study of the role of uric acid in metabolic status modification.

Methods and results. We determined the main anthropometric indices, serum uric acid, fasting glucose, 2-hours glucose after tolerance test, total cholesterol, LDL, HDL, triglycerides. More expressed metabolic violations in patients with gout which was combined with arterial hypertension were found.

Conclusion. Increasing of uric acid concentration was associated with high level of 2-hours glucose after tolerance test and affected to HDL rate decreasing and  triglycerides level increase.

References

Barskova, V. G., Il`inyikh, E. V., Eliseev, M. S., Zilov, A. V., & Nasonov, E. L. (2006). Kardiovaskulyarnyj risk u bol`nykh podagroj [Cardiovascular risk in patients with gout]. Ozhirenie i metabolizm, 3(8), 40–44. [in Russian].

Bil`chenko, A. V. (2009). Giperurikemiya kak faktor riska serdechno-sosudistoj zabolevaemosti i smertnosti [Hyperuricemia as a risk factor for cardiovascular morbidity and mortality]. Zdorovia Ukrainy, 10(1), 46–48. [in Ukrainian].

Dziak, H. V., & Homaziuk, T. A. (2010). Podagra: «kapkan metabolIchnih problem» [Gout: `trap of metabolіc problems`]. Dnipropetrovsk: Roial print. [in Ukrainian].

Puzanova, O. G., & Taran, A. I. (2009). Giperurikemiya i kardiovaskulyarnyj kontinuum [Hyperuricemia and cardiovascular continuum]. Vnutrishnia medytsyna, 3, 9–17. [in Ukrainian].

Choi, H. K., Ford, E. S., Li, C., & Curhan, G. (2007). Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey. Arthritis Rheum., 57, 109 –115.

Kim, S. Y., Guevara, J. P., Kim, K. M., Choi, H. K., Heitjan, D. F., & Albert, D. A. (2010). Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res, 62(2), 170–80. doi: 10.1002/acr.20065

Krishnan, E. (2012). Gout and the risk for incident heart failure and systolic dysfunction. BMJ Open, 15, 26–30. doi: 10.1136/bmjopen-2011-000282.

Sundstrom, J., Sullivan, L., D'Agostino, R. B., Levy, D., Kannel, W. B., & Vasan, R. S. (2005). Relation of serum uric acid to longitudinal blood pressure traching and hypertension incidence. Hypertension, 45, 28–33. doi: 10.1161/01.HYP.0000150784.92944.9a.

How to Cite

1.
Daniuk ІO. Metabolic disorders in men with primary gout and hypertension syndrome. Zaporozhye Medical Journal [Internet]. 2015Jun.15 [cited 2024Dec.2];17(3). Available from: http://zmj.zsmu.edu.ua/article/view/44484

Issue

Section

Original research